Cleopatra Hospital is trading 3.16% down at $16.84, with no clear company-specific catalyst identified for September 8, 2026.

  • The latest company item was a September 6 report highlighting H1 revenue of EGP 4.3 billion; available coverage provides no causal link to the decline.
  • Broader sentiment was mixed-to-lower, with the Dow down 0.75% and S&P 500 down 0.37%, insufficient to confirm a direct global-market explanation.